Protalix Biotherapeutics, Inc.(NYSE Amex Equities : PLX)
PLX PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
Health Services » Servicestothe Health Industry
|LH||Laboratory Corp. of America Holdings||0.04%||276.19||2.4%||$231.03m|
|IQV||IQVIA Holdings, Inc.||0.04%||247.44||0.0%||$188.63m|
|DGX||Quest Diagnostics, Inc.||-0.02%||142.27||4.7%||$151.38m|
|AMEH||Apollo Medical Holdings, Inc.||0.00%||60.35||0.0%||$22.39m|
|BASI||Bioanalytical Systems, Inc.||0.00%||32.86||0.2%||$3.39m|
|NRC||National Research Corp.||0.00%||38.21||0.0%||$1.33m|
|PLX||Protalix Biotherapeutics, Inc.||-1.14%||0.85||18.5%||$0.46m|
|QIPT||Quipt Home Medical Corp.||-0.18%||5.65||0.0%||$0.24m|
Protalix Biotherapeutics, Inc. is a biopharmaceutical company, which engages in the development, production, and commercialization of recombinant therapeutic proteins based on plant cell based expression system. Its products include Alidornase alfa, PRX-115 and PRX-11. The company was by Yoseph Shaaltiel in 1993 and is headquartered in Hackensack, NJ.